Literature DB >> 30603321

Cognitive impairment in elderly patients with type 2 diabetes mellitus: prevalence and related clinical factors.

Yuko Murata1, Yoshiki Kadoya1, Shoichi Yamada1, Tokio Sanke2.   

Abstract

AIM: Diabetes mellitus is reported to be a risk factor for dementia. We evaluated the cognitive function in elderly diabetic patients and estimated the prevalence of patients with cognitive impairment and looked for any related clinical factors. SUBJECTS AND METHODS: Using 281 elderly (65 years of age or older) Japanese patients with type 2 diabetes mellitus who were free of clinically evident cognitive impairment, we evaluated their cognitive function with the Mini Mental State Examination (MMSE).
RESULTS: The MMSE score of all the participants was 27.3 ± 2.4 with 31.3% of them being in the abnormal range (tentatively defined normal range as having an MMSE score of 27-30). Multiple regression analysis disclosed that fasting serum non-esterified fatty acid (NEFA), estimated glomerular filtration ratio (eGFR) and insulin treatment were significantly related factors for the MMSE score, in addition to age and schooling history, which are extremely strong factors.
CONCLUSIONS: We revealed that approximately one-third of elderly type 2 diabetic patients who were free of clinically evident cognitive impairment had impaired cognitive function, demonstrating that the MMSE score was significantly correlated with fasting NEFA level, renal function, insulin treatment, age and schooling history.

Entities:  

Keywords:  Cognitive impairment; Elderly patient; Mini Mental State Examination; Non-esterified fatty acid; Type 2 diabetes mellitus

Year:  2016        PMID: 30603321      PMCID: PMC6224960          DOI: 10.1007/s13340-016-0292-9

Source DB:  PubMed          Journal:  Diabetol Int        ISSN: 2190-1678


  25 in total

1.  "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician.

Authors:  M F Folstein; S E Folstein; P R McHugh
Journal:  J Psychiatr Res       Date:  1975-11       Impact factor: 4.791

2.  Use of the GDS-15 geriatric depression scale as a screening instrument for depressive symptomatology in patients with Parkinson's disease and their carers in the community.

Authors:  J Meara; E Mitchelmore; P Hobson
Journal:  Age Ageing       Date:  1999-01       Impact factor: 10.668

Review 3.  Fatty acid intake and the risk of dementia and cognitive decline: a review of clinical and epidemiological studies.

Authors:  S Kalmijn
Journal:  J Nutr Health Aging       Date:  2000       Impact factor: 4.075

4.  Hyperinsulinemia and cognitive decline in a middle-aged cohort.

Authors:  Sara E Young; Arch G Mainous; Mark Carnemolla
Journal:  Diabetes Care       Date:  2006-12       Impact factor: 19.112

5.  Investigation on the relationship between diabetes mellitus type 2 and cognitive impairment.

Authors:  S A Ebady; M A Arami; M H Shafigh
Journal:  Diabetes Res Clin Pract       Date:  2008-10-09       Impact factor: 5.602

6.  Hypoglycemic episodes and risk of dementia in older patients with type 2 diabetes mellitus.

Authors:  Rachel A Whitmer; Andrew J Karter; Kristine Yaffe; Charles P Quesenberry; Joseph V Selby
Journal:  JAMA       Date:  2009-04-15       Impact factor: 56.272

7.  Treatment of vascular risk factors is associated with slower decline in Alzheimer disease.

Authors:  Yan Deschaintre; Florence Richard; Didier Leys; Florence Pasquier
Journal:  Neurology       Date:  2009-09-01       Impact factor: 9.910

Review 8.  Risk of dementia in diabetes mellitus: a systematic review.

Authors:  Geert Jan Biessels; Salka Staekenborg; Eric Brunner; Carol Brayne; Philip Scheltens
Journal:  Lancet Neurol       Date:  2006-01       Impact factor: 44.182

9.  Relationships between daily acute glucose fluctuations and cognitive performance among aged type 2 diabetic patients.

Authors:  Maria Rosaria Rizzo; Raffaele Marfella; Michelangela Barbieri; Virginia Boccardi; Francesco Vestini; Biagio Lettieri; Silvestro Canonico; Giuseppe Paolisso
Journal:  Diabetes Care       Date:  2010-06-23       Impact factor: 19.112

10.  Medium-chain fatty acids improve cognitive function in intensively treated type 1 diabetic patients and support in vitro synaptic transmission during acute hypoglycemia.

Authors:  Kathleen A Page; Anne Williamson; Namyi Yu; Ewan C McNay; James Dzuira; Rory J McCrimmon; Robert S Sherwin
Journal:  Diabetes       Date:  2009-02-17       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.